LGM Pharma News and Resources

LGM Pharma has announced a $6 million investment to expand its Rosenberg, Texas, manufacturing facility, strengthening its position as a U.S.-based contract development and manufacturing organisation (CDMO). The expansion will enhance production capacity for liquid, suspension, semi-solid, and suppository drug products,

LGM Pharma has announced the expansion of its Analytical Testing Services with the introduction of endotoxin and rapid sterility testing at its Irvine, California facility. This move responds to growing demand for reliable and fast testing for sterile compounds, offering

LGM Pharma, a provider of tailored API and CDMO services for the full drug product lifecycle, has announced a significant enhancement of its capabilities. The company has made a 50% expansion and an investment exceeding $2 million in its standalone offering